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INTRODUCTION  
Schizophrenia is a complex illness that does not follow scientific explanation for all the aspects 
of the illness from overt behavior to the intracellular changes (Carroll and Owen, 2009). Till 
date, the researchers have not been able to identify even a single factor which can commonly 
explain/define all patients with schizophrenia. In spite of the challenges, still, many researchers 
have put most of the pieces in proper place in this field but the puzzle is still unsolved (Walker et 
al, 2004). 
It is important to know the health beliefs of the individuals suffering from psychiatric disorders. 
These beliefs are the main factors in health models and illness related behaviour, and so they 
might affect clinical outcome, because these are directly related to patient's own viewpoint about 
his illness and treatment option (Williams and Healy, 2001). In the treatment process, the patient 
has now been considered an active partner because of the move towards patient centered care. 
For making the patient more active in the care process it is important to illustrate patient’s own 
perspective of the treatment plan. This demands the exploration of the patients views about their 
illness and then addressing those views to strengthen therapeutic relationship and treatment 
effectiveness (McCabe and Priebe, 2004a). The pioneering explanatory approach developed by 
Klienman involved asking explanatory questions in a qualitative approach (Bhui and Bhugra, 
2002). Beliefs about illness hold by the patients and their families effect their decisions about the 
consultation for the treatment  and also perseverance of symptoms and the level of disability 
caused by illness. Illness perception models have theoretical structures to systemized the 
information about patients’ beliefs and expectations and to explore their perceptions about the 
causes and consequences. These factors can strongly predict the outcomes related to health 
(Sumathipala et al, 2008). 
For the last few decades, there is rising interest in how individuals think about their illnesses and 
how these explanations are different in culture (Mccabe and Priebe, 2004b). Explanatory models 
greatly differ from culture to culture and even within the culture, and it is proved by evidence. 
However very less research has been done on how these model differ across divergent 
exploratory framework (Lynch and Medin, 2006). 
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Evidence shows that patients with schizophrenia learn a lot through psychological interventions 
which help them to improve their quality of life. For the last 4 decades, psychoeducation is 
getting importance in the treatment of schizophrenia and other psychotic disorders. Number of 
psychoeducational approaches have developed in health psychology, specifically for patients 
with schizophrenia who are on antipsychotic medications and have problems of obesity and 
metabolic syndrome. Psychoeducational intervention designed for these problems help patients 
to adapt healthier lifestyle and dietary plans (Bisbee and Vickar, 2012). Furthermore, it is also a 
fact that these interventions are very helpful in reducing family burden, which is again associate 
in reduction of indirect costs due to loss of productivity of family members (Pingani et al, 2013). 
According to Cochrane analysis, psychoeducational interventions showed decrease rate of 
relapse, better compliance level, and improvement in psychopathology (Pekkala and Merinder, 
2002; Magliano et al, 2006). Compliance is not that uncommon and the treating psychiatrist has 
to be mindful of it. Compliance counseling is important part of psychoeducation. Studies focused 
on educational formats have influenced improvements in general understanding of schizophrenia 
and its treatment (Turkington et al, 2006). 
There is dearth of research on explanatory model of illness of psychosis in our settings and the 
inadequate and inaccurate knowledge about schizophrenia in general population is well 
documented (John, 1992.). It has been revealed that gaps between patients and mental health 
professionals understanding may affect help-seeking behaviour, adherence to medication and 
provision of effective psychosocial therapy. Dissonance between cultural and scientific 
explanations further deteriorates the much needed therapeutic relationship and long-term care of 
schizophrenia. To improve patient outcome, health professionals need to look at wider picture of 
illness rather than scientific model of disease and develop good communication skills to gain 
patients’ trust. Therefore, we investigated the explanatory models of illness in patients suffering 
from Schizophrenia in our setting to find out the role of educational intervention, which is 
expected to be beneficial not only for the patients, caregivers and mental health professionals but 







This was a randomized controlled trial, conducted to explore the effectiveness of Structured 
Educational Intervention. The study consisted of two groups, i.e. the control group and the 
experimental group. Structured Educational Intervention was applied on the experimental group 
only, and, the control group received treatment as usual (TAU) only. The trial was approved by 
the Research Ethics Committee of Lady Reading Hospital Peshawar, Pakistan and was 
conducted in compliance with the Declaration of Helsinki.  
Instruments 
Semi structured-interview was conducted at first on all the patients in order to get basic 
sociodemographic information and to satisfy the diagnosis according to ICD-10 criteria.   
The first scale we used was Short Explanatory Model Interview version 3.0 (Mirza et al. 2006) 
which elicited the patients’ concepts, causes, treatment choice and severity of the illness, 
responses of the patients were recorded in a written verbatim form. SEMI has been designed in a 
simple way that it can be easily used in day to day clinical practice and research. The language 
used in the scale is non-technical and can be easily translated. It does not require any special 
training for the interviewer from any background. Qualitative analysis methods are suitable for 
the analysis of the data taken from this tool. 
Positive and Negative syndrome scale (Kay et al, 1987) was applied to measure the severity of 
the symptoms. It is a 30 item rating scale, designed to assess individuals with schizophrenia and 
other psychotic disorders and is widely used in research settings. Items are divided into 7 
positive items, 7 negative and the remaining 16 constitute general psychopathology scale. Each 
item is scored from 1 to 7 and total scores are obtained by the sum of ratings of each component 
of the scale. Therefore, possible ranges of score are 7-49 for the positive and negative scales, 
and 16 -112 for the general psychopathology. 
Global assessment of Functioning was administered to rate the functioning of the patients. GAF 
is representation of clinical interpretation through numerical approach to the person’s overall 
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functioning level. Impaired functioning in psychological, social, occupational and academics are 
taken under consideration. The scale ranges from 0 (inadequate information) to 100 superior 
functioning or having no impairment at all. 
Brief Psychiatric Rating Scale (Leucht et al, 2005) was also applied on all the patients in order 
to rate the psychotic behavior of the patients. It is one of the most widely used instrument for 
assessing psychopathology in patient suffering from schizophrenia. BPRS includes 5 sub scales, 
i.e., Thought disorder, Withdrawal, Anxiety /Depression, Hostility and Activity, which is 
symbolically denoted as (TD), (W), (AD), (H), and (A) respectively. 
Compliance Rating Scale (Herz et al, 2000) was administered to check the patient’s adherence 
to treatment. It has three measures. None, partial and complete compliance. However, for the 
sake of analysis, none and partial were combinedly considered as non-compliance. 
All these scales were administered on all the patients on baseline and on 3 months follow up. 
Setting 
This randomized controlled trial was conducted at the inpatient care of the department of 
Psychiatry, Lady Reading Hospital, Peshawar from February to August 2015. This department 
has the capacity of 36 beds for in-patients, both male and female. It is one of the very few 
purpose built departments of Psychiatry in Pakistan, catering for patients of almost all sub 
specialties of Psychiatry.  
 
Procedure 
All the patients who visited psychiatric OPD and diagnosed by the consultant psychiatrist as 
schizophrenia were referred to the researcher after prescribing medications. Outline of the 
research was given to all the patients and after getting their willingness for the participation in 
the research, written Informed consent was taken from the patients and attendants. Patients who 
fulfilled the inclusion criteria were randomly assigned to each treatment group using computer 
generated randomization method. After complete assessment, the patients who were included in 
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the experimental group were administered Structured Educational Intervention 19, which was 
repeated once in a month. 
Participants 
Patients who fulfilled the ICD-10 diagnostic criteria for schizophrenia were included in the study 
with their relatives. Patients with any other psychiatric co morbidity, for example Learning 
Disability or with any severe physical problem were excluded. Patients who were not able to 
respond or communicate were also excluded. 
Figure 1 here  
A total of 121 participants were referred (figure 1) and 103 were randomised; 53 were 
randomized to the intervention arm and 50 were randomized to the control (Treatment As Usual, 
TAU) arm .  
Sample size  
Based on the prevalence reported in a previous study and using WHO sample size calculation 
software, a total of 103 patients were included in the study. 
Randomization 
After completion of the assessment, participants were randomized to two groups i.e., TAU and 
experimental by using computer generated randomization method. The allocation list was kept in 
a remote secure location, and an independent person randomly allocated the included participants 
after they signed informed consent. 
Drop outs 
Eighteen cases that were referred for recruitment did not gave consent and were excluded from 
randomization. We obtained contact numbers and consent from participants at baseline to contact 
them in future, if needed. Seven patients from experimental group did not complete their follow 




The original intervention was developed by Smith and Birchwood in 1987 (Smith and 
Birchwood, 1987). For our trial, it was translated in local language by a group of four mental 
health professionals including two consultant psychiatrists and two psychologists using back 
translation method, which was later verified by an expert in English and local language. It was 
provided to experimental group once in a month for three months by the researcher.  
The intervention had four parts, first part was about giving simple explanations of possible 
causal factors, e.g. the role of genetic and biochemical abnormalities, second section focused on 
the nature of schizophrenia, describing common symptoms and behaviors in terms of 
disturbances in thinking, feelings and behavior, third section described the function of the 
relevant psychiatric services and the role of neuroleptic medication in acute and maintenance 
phases, fourth section was concerned with helping relatives to identify support services in terms 
of hospital and community resources available. All the patients of both arms were reassessed 
after 3 months’ follow-up. The scale mentioned above were applied once again after 3 months to 
see if there was any difference between the two groups related to the improvement and illness 
perception. Reassessment was carried out by an independent scorer to reduce biasness.  
TAU group 
The Treatment As Usual (TAU) group received the treatment provided by the consultant 
psychiatrist in routine clinical care in their practice. This normally consists of prescribing 
antipsychotic medication as considered suitable by the treating psychiatrist and nursing care. 
Statistical Analyses 
We followed the CONSORT guidelines for randomized controlled trials (Moher et al, 2001). We 
used SPSS version 20 for the data analysis. Mean and SD were calculated using t test for the 
quantitative data. Content analysis was used for the analysis of the qualitative data. Responses to 
the SEMI questions concerning concept, severity, course, aetiology and treatment from the 
sample of both groups were content analyzed. Codes were given to frequently occurred items. 




Participants Description and Other Characteristics at Baseline 
The mean age of the sample was 30.5+9.4 years with majority of males (n=80, 77%) in the 
sample. The mean duration of the illness was 78.4+6.0 months. Fifteen (14.6%) were 
unemployed, 54 (52.4%) were employed, 22 (21.4%) were house ladies and 12 (11.6%) were 
students. There were 25(24.3%) patients who had no formal education, seventy-seven (74.4%) 
were living in joint family system and 62 (60.2%) belonged to rural area. From total sample, 
28(27.2%) had received non pharmacological intervention in the past. Differences in 
demographic and clinical variables at baseline are given in Table 1. 
 
Table 1 here 
 
Symptoms measure 
There was significant difference on the scores between the two groups, at follow up, on the 
psychometric tools, i.e., Brief Psychiatric Rating Scale, BPRS (0.002), Positive and negative 
syndrome scale, PANSS Total (0.000), Global Assessment of Functioning, GAF (0.000).  
 
Table 2 here  
 
Compliance  
As measured by Compliance rating scale, there was no significant difference in compliance to 
the antipsychotic medication on baseline of TAU and experimental group, as there were 23 
(46%) patients in TAU while 13 (24.5%) in experimental group who had complete compliance 
rate at baseline (p = 0.022). On follow up, there were 17 (47.2%) cases in the TAU group and 
44(95.6%) cases in the experimental group with complete compliance (p = 0.000). 
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Short Explanatory Model Interview (SEMI) 
The major concept of patients on Short Explanatory Model Interview (SEMI) was mental illness 
(without naming). This was consistent on baseline [TAU (20, 40.0%), Experimental (14, 26.4%) 
(p=0.143)], as well as on follow up [TAU (15, 41.7%), Experimental (14, 30.5%) (p=.291)]. 
Patients mostly attributed at both baseline and follow up, stress [Experimental (18, 33.9%), TAU 
(6, 12.0%), p=.008 and Experimental (32, 69.6%), TAU (4, 11.1%), p=.000] and spiritual 
[Experimental (10, 18.8%), TAU (7, 14.0%), p=.506 and Experimental (3, 6.5%), TAU (4, 
11.1%), p=.460] as causes to their illness. However, the description of biological and 
supernatural cause of their illness was increased more at follow up in experimental and TAU 
group, respectively (p=0.000 & p=0.000). Regarding treatment choice patient reported their 
preferences as medication only at baseline [Experimental (13, 24.5%), TAU (11, 22.0%)] and 
medication with spiritual healing [Experimental (28, 52.9%), TAU (29, 58.0%)] which at follow 
up changed to a majority considering medication only as treatment choice [Experimental (26, 
56.5%), TAU (17, 47.1%)]. Considering the illness as very serious, there was no significant 
difference between both the groups at baseline (p=.876) while it was significant at follow up 
(p=.003).  
 











This RCT attempted to assess the explanatory model of illness of patients with schizophrenia and 
the role of structured educational intervention in modifying their EMs. It discussed patients’ 
beliefs and presented alternative biomedical explanations for schizophrenia. We combined the 
qualitative and quantitative methodologies.   
Few studies have so far attempted to modify the explanatory models by applying educational 
interventions (Bhikha et al, 2012). These interventions directed to acquire significant information 
about schizophrenia, equally across all relevant knowledge areas including improved optimism 
regarding the family member's role in sustaining the patient's well-being, reduced level of family 
member's anxiety, and improvements in social independence (competence), and that knowledge 
was maintained at six-month follow-up (Smith and Birchwood, 1987). Significant difference was 
found in the level of knowledge and information about schizophrenia at follow up assessment as 
compared to the baseline information of our sample. Patients acquired satisfactory knowledge 
about the disorder including concepts and causes for developing schizophrenia after receiving 
educational intervention for three months. People became aware of the name of their illness i.e., 
Schizophrenia [25(54.3%)]. Spiritual issue as a cause decreased [3(6.5%)]. Biological causes’ 
awareness had significantly improvement [15 (32.6%)]. The finding as stress being the cause is 
in line with Stress vulnerability model. Treatment choices did not change even after the 
intervention because people were already taking medication. However, it should be noted that 
the participants using treatment only in experimental group got doubled [26(56.5%)] TAU group 
when treated thought it is not “very serious”, highlighting the possibility of non-Compliance, in 
comparison to Experimental group (p=.003) 
In this study there were more male patients in each arm comprising 80% of each group. Previous 
evidence suggested that schizophrenia develops equally in the genders (Dohrenwend and 
Dohrenwend, 1974; Lewine and Meltzer, 1984), current research data suggests that incidence 
rates are higher among men than women (Iacono and Beiser, 1992). It appears that predominance 
of male subjects in our study is due to differential help seeking patterns, in which female patients 
are likely to be brought to the hospital only when they are most severely ill. The cultural norms 
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in our society and stigma attached to the severe mental illness such as Schizophrenia perhaps 
results in female patients less likely to presenting in the tertiary care centers.   
In a systematic review on antipsychotics (Lepping et al, 2011) it was found that the mean score 
on PANSS of patients with schizophrenia on baseline was 81.05(12.73) and it was 64.77(11.29) 
on follow up which is again close to our findings. There was difference between the mean score 
of PANSS at baseline and on follow up of our experimental group with the p value of 0.00, 
which shows that the intervention proved to be effective in improving the symptomatology of the 
patients. We found significant difference in the level of GAF of experimental group at the end of 
the intervention. In a study conducted for exploring the specific and non-specific effects of 
educational intervention for families living with schizophrenia (Smith and Birchwood, 1987), 
that the GAF of the sample got improved after three months’ follow-up. The study also reported 
that significant improvements in social functioning are observed at six months. 
Psycho education about the compliance should be routinely offered to all patients with 
schizophrenia and their families (Pitschel-Walz et al, 2006). It improves adherence and motivates 
patients to accept a maintenance therapy as recommended by the guidelines (Bauml et al, 2016). 
Our study found that the part of the intervention related to compliance to the antipsychotic drugs 
was effective as compliance rate of the experimental group was improved on follow-up 
assessment as compared to the TAU group (p=0.000). This is comparable with another study that 
demonstrated the importance of education on the compliance, as well as on the positive attitude 
towards the drug treatment, which is one of the most important predictors of the successful 
treatment of the schizophrenia (Degmecic et al, 2007). 
Help can be sought from different sources e.g., mental health practitioner, spiritual healer, 
religious healer, etc, no matter what kind of health model patient hold a patient holds(Das 
2006). We did not find significant difference in the treatment choice on pre and post 
assessment, suggesting that while people may acknowledge causal medical Explanatory 
Models, they reserve the right to seek all available therapies, medical and non-medical, to 




There is a rich diversity of beliefs in the knowledge of explanatory models but within this 
mixture are a number of shared concepts in different cultures (Patel, 1995). There are obvious 
differences in patterns of health and illness across cultures, over time, and within 
particular society types(Williams 2001). Explanatory models are influenced by culture. 
People share common beliefs about health and illnesses within the same culture(Fox 2005).
The models of illness impact upon help-seeking behaviours and care pathways, southasian 
patient’s beliefs were similar to the people from the same culture (Bhikha 2015).As we too 
observed that patients from our sample hold the beliefs about the disorder, which are common in 
Asian culture.We could elicit multiple concepts and causes by exploring the health models of the 
patients.  
It has long been considered that psychosocial stress plays a role in the expression of symptoms in 
schizophrenia. Stress was frequently reported cause by our patients, they attributed tension/stress 
of psychosocial stressors to the development of their illness. A study reported that 46% of 50 
patients with schizophrenia had been exposed to stressful life events in the preceding 3 months 
as compared to only 14% of 325 controls (Corcoran et al, 2002).  
Spiritual and traditional healers have historically provided ‘healing’ through various spiritual and 
medical modalities (Leayey et al, 2016) they are still an important help-seeking resource for the 
mental health problems. This is very common in Asian culture (Mojaverian et al, 2012). We too 
observed in our study that more than 50% of our patients were visiting spiritual healers for the 
treatment of the illness.  
The educational intervention was effective in improving the concepts of the patients as at the end 
54.3 % (p=0.000) from experimental group named the illness as schizophrenia. In contrast, a 
study on the explanatory model of illness of ethnic groups (Mccabe and Priebe, 2004) reported 
that 20% of the total sample called their illness as schizophrenia. 
Various explanatory models are considered as norms in Asian cultures so the education 
about mental illness should present biomedical model without dismissing local EMs. 
Biopsychosocial explanations should not claim superiority or exclusivity over local models. 
People should be encouraged to employ diverse approaches to manage their mental 




Our sample consisted of patients who had different educational status, if all the patients were of 
same educational background we could have control the skewness of the results to some extent. 
The persistence of changes in beliefs and its effect on compliance have to be reconfirmed after 
some time. We used only verbal communication for the impartment of the knowledge. Although 
it proved to be effective but keeping in view the socio demographics of the sample, audio/visual 



















In our settings, beliefs, concepts and ideas of the patients with schizophrenia about their illness 
contradict the biopsychosocial model. Our sample believed that there are other reasons like 
spiritual and supernatural which have caused the illness. We also concluded that such beliefs and 
concepts need to be explored and discussed before exposing the patients to psychological 
interventions. Patients prefer to visit spiritual healers for help along with taking medication. 
Furthermore, the results of the study suggest that educational interventions can alter the non-
biomedical explanatory models of patients with schizophrenia, which is directly related to the 
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